Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Intraprostatic inflammation is an emerging prostate cancer risk factor. Estrogens are pro‐inflammatory while androgens are anti‐inflammatory. Thus, we investigated whether serum sex steroid hormone concentrations are associated with intraprostatic inflammation to inform mechanistic links among hormones, inflammation, and prostate cancer.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>We conducted a cross‐sectional study among 247 men in the placebo arm of the Prostate Cancer Prevention Trial who had a negative end‐of‐study biopsy, most (92.7%) performed without clinical indication per trial protocol. Serum estradiol, estrone, and testosterone were previously measured by immunoassay in pooled baseline and Year 3 serum. Free estradiol and free testosterone were calculated. Inflammation was visually assessed (median of three prostate biopsy cores per man). Polytomous or logistic regression was used to estimate the odds ratio (OR) and 95% confidence interval (CI) of some or all cores inflamed (both vs none) or any core inflamed (vs none) by hormone tertile, adjusting for age, race, and family history. We evaluated effect modification by waist circumference and body mass index (BMI).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>In all, 51.4% had some and 26.3% had all cores inflamed. Free (<i>P </i>‐trend = .11) but not total estradiol was suggestively inversely associated with all cores inflamed. In men with waist circumference greater than or equal to 102 cm (<i>P </i>‐trend = .021) and BMI ≥ 27.09 kg/m<sup>2</sup> (<i>P </i>‐trend = .0037) free estradiol was inversely associated with any core inflamed. Estrone was inversely associated with all cores inflamed (T3: OR = 0.36, 95% CI 0.14‐0.95, <i>P </i>‐trend = .036). Total (T3: OR = 1.91, 95% CI 0.91‐4.02, <i>P </i>‐trend = .11) and free (T3: OR = 2.19, 95% CI 1.01‐4.74, <i>P </i>‐trend = .05) testosterone were positively associated with any core inflamed, especially free testosterone in men with waist circumference less than 102 cm (T3: OR = 3.51, 95% CI 1.03‐12.11, <i>P </i>‐trend = .05). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>In this first study in men without prostate cancer and irrespective of clinical indication for biopsy, contrary to the hypothesis, circulating estrogens appeared to be inversely associated, especially in heavy men, whereas androgens appeared to be positively associated with intraprostatic inflammation.</p></section>

The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial

Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention Trial

Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial

Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial

Endogenous Sex Hormones and Colorectal Cancer Survival among Men and Women.

Investigation of association between clinically significant prostate cancer, obesity and platelet to-lymphocyte ratio and neutrophil -to-lymphocyte ratio

Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial

A Prospective Study of Intraprostatic Inflammation, Focal Atrophy, and Progression to Lethal Prostate Cancer

Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia

A new era of testosterone and prostate cancer: from physiology to clinical implications

Premenopausal serum androgens and breast cancer risk: a nested case-control study

Plasma Carotenoids and Tocopherols in Relation to Prostate-Specific Antigen (PSA) Levels among Men with Biochemical Recurrence of Prostate Cancer

Negative Association between Testosterone Concentration and Inflammatory Markers in Young Men: A Nested Cross-Sectional Study

Circulating and Intraprostatic Sex Steroid Hormonal Profiles in Relation to Male Pattern Baldness and Chest Hair Density among Men Diagnosed with Localized Prostate Cancers

Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies

Intraprostatic Chronic Inflammation is Associated with a Reduced Risk of Prostate Cancer in Patients Elected to a First Random Biopsy Set

Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS)

Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis

The role of endogenous testosterone in relationship with low- and intermediate-risk prostate cancer: a systematic review

Endogenous sex hormones and C-reactive protein in healthy Chinese men.

Selenium and Sex Steroid Hormones in a U.S. Nationally Representative Sample of Men: A Role for the Link between Selenium and Estradiol in Prostate Carcinogenesis?